Milbemycin is a new type of semi-synthetic macrolide anthelmintic. It is an oxime derivative of Milbemycin A3 and A4. The molecular weight of A3 oxime is 541.7, and the molecular weight of A4 oxime is 555.7. In terms of application, milbexime can be used alone or in combination with nitenpyram, lufenuron, spinosad, praziquantel, etc. to form a compound preparation, which can effectively prevent and control heartworms, hookworms, roundworms, whipworms, roundworms and other internal parasites, as well as hair follicles, scabies, lice, fleas and other external parasites. Milbexime acts as an agonist of the GABA (gamma-aminobutyric acid) neurotransmitter in nerve cells and also binds to glutamate-gated Cl– channels in invertebrate nerve and muscle cells. In both cases, it blocks the parasite's nerve signaling, eventually paralyzing the parasite, causing the muscles to lose their ability to contract, stop feeding, and cause the parasite to die.
The global Milbemycin Oxime API market is projected to grow from US$ 209.4 million in 2024 to US$ 304 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.4% during the forecast period.
Global 3 largest manufacturers of Milbemycin Oxime API are Livzon Pharmaceutical Group Inc, Zhejiang Hisun Pharmaceutical Co., Ltd and Hubei Honch Pharmaceutical Co.,Ltd, which make up over 40%. Among them, Livzon Pharmaceutical Group Inc is the leader with about 22% market share. North America is the largest market, with a share about 48%, followed by Europe and China, with the share about 46% and 2%. In terms of product type, Purity Greater than 98% occupy the largest share of the total market, about 85%. And in terms of product Application, the largest application is Dog, followed by Cat.
In terms of production side, this report researches the Milbemycin Oxime API production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.
In terms of consumption side, this report focuses on the sales of Milbemycin Oxime API by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.
Report Covers:
This report presents an overview of global market for Milbemycin Oxime API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Milbemycin Oxime API, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Milbemycin Oxime API, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Milbemycin Oxime API sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Milbemycin Oxime API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Milbemycin Oxime API sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Livzon Pharmaceutical Group Inc
Zhejiang Hisun Pharmaceutical Co., Ltd
Hubei Honch Pharmaceutical Co.,Ltd
JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD
Segment by Type
98% Purity
Purity Greater than 98%
Segment by Application
Dog
Cat
Other
Production by Region
China
Sales by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Milbemycin Oxime API production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Milbemycin Oxime API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Milbemycin Oxime API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Milbemycin Oxime API sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Milbemycin Oxime API Product Introduction
1.2 Market by Type
1.2.1 Global Milbemycin Oxime API Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 98% Purity
1.2.3 Purity Greater than 98%
1.3 Market by Application
1.3.1 Global Milbemycin Oxime API Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Dog
1.3.3 Cat
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Milbemycin Oxime API Production
2.1 Global Milbemycin Oxime API Production Capacity (2019-2030)
2.2 Global Milbemycin Oxime API Production by Region: 2019 VS 2023 VS 2030
2.3 Global Milbemycin Oxime API Production by Region
2.3.1 Global Milbemycin Oxime API Historic Production by Region (2019-2024)
2.3.2 Global Milbemycin Oxime API Forecasted Production by Region (2025-2030)
2.3.3 Global Milbemycin Oxime API Production Market Share by Region (2019-2030)
2.4 China
3 Executive Summary
3.1 Global Milbemycin Oxime API Revenue Estimates and Forecasts 2019-2030
3.2 Global Milbemycin Oxime API Revenue by Region
3.2.1 Global Milbemycin Oxime API Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Milbemycin Oxime API Revenue by Region (2019-2024)
3.2.3 Global Milbemycin Oxime API Revenue by Region (2025-2030)
3.2.4 Global Milbemycin Oxime API Revenue Market Share by Region (2019-2030)
3.3 Global Milbemycin Oxime API Sales Estimates and Forecasts 2019-2030
3.4 Global Milbemycin Oxime API Sales by Region
3.4.1 Global Milbemycin Oxime API Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Milbemycin Oxime API Sales by Region (2019-2024)
3.4.3 Global Milbemycin Oxime API Sales by Region (2025-2030)
3.4.4 Global Milbemycin Oxime API Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Milbemycin Oxime API Sales by Manufacturers
4.1.1 Global Milbemycin Oxime API Sales by Manufacturers (2019-2024)
4.1.2 Global Milbemycin Oxime API Sales Market Share by Manufacturers (2019-2024)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Milbemycin Oxime API in 2023
4.2 Global Milbemycin Oxime API Revenue by Manufacturers
4.2.1 Global Milbemycin Oxime API Revenue by Manufacturers (2019-2024)
4.2.2 Global Milbemycin Oxime API Revenue Market Share by Manufacturers (2019-2024)
4.2.3 Global Top 10 and Top 5 Companies by Milbemycin Oxime API Revenue in 2023
4.3 Global Milbemycin Oxime API Sales Price by Manufacturers
4.4 Global Key Players of Milbemycin Oxime API, Industry Ranking, 2022 VS 2023 VS 2024
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Milbemycin Oxime API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Milbemycin Oxime API, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Milbemycin Oxime API, Product Offered and Application
4.8 Global Key Manufacturers of Milbemycin Oxime API, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Milbemycin Oxime API Sales by Type
5.1.1 Global Milbemycin Oxime API Historical Sales by Type (2019-2024)
5.1.2 Global Milbemycin Oxime API Forecasted Sales by Type (2025-2030)
5.1.3 Global Milbemycin Oxime API Sales Market Share by Type (2019-2030)
5.2 Global Milbemycin Oxime API Revenue by Type
5.2.1 Global Milbemycin Oxime API Historical Revenue by Type (2019-2024)
5.2.2 Global Milbemycin Oxime API Forecasted Revenue by Type (2025-2030)
5.2.3 Global Milbemycin Oxime API Revenue Market Share by Type (2019-2030)
5.3 Global Milbemycin Oxime API Price by Type
5.3.1 Global Milbemycin Oxime API Price by Type (2019-2024)
5.3.2 Global Milbemycin Oxime API Price Forecast by Type (2025-2030)
6 Market Size by Application
6.1 Global Milbemycin Oxime API Sales by Application
6.1.1 Global Milbemycin Oxime API Historical Sales by Application (2019-2024)
6.1.2 Global Milbemycin Oxime API Forecasted Sales by Application (2025-2030)
6.1.3 Global Milbemycin Oxime API Sales Market Share by Application (2019-2030)
6.2 Global Milbemycin Oxime API Revenue by Application
6.2.1 Global Milbemycin Oxime API Historical Revenue by Application (2019-2024)
6.2.2 Global Milbemycin Oxime API Forecasted Revenue by Application (2025-2030)
6.2.3 Global Milbemycin Oxime API Revenue Market Share by Application (2019-2030)
6.3 Global Milbemycin Oxime API Price by Application
6.3.1 Global Milbemycin Oxime API Price by Application (2019-2024)
6.3.2 Global Milbemycin Oxime API Price Forecast by Application (2025-2030)
7 US & Canada
7.1 US & Canada Milbemycin Oxime API Market Size by Type
7.1.1 US & Canada Milbemycin Oxime API Sales by Type (2019-2030)
7.1.2 US & Canada Milbemycin Oxime API Revenue by Type (2019-2030)
7.2 US & Canada Milbemycin Oxime API Market Size by Application
7.2.1 US & Canada Milbemycin Oxime API Sales by Application (2019-2030)
7.2.2 US & Canada Milbemycin Oxime API Revenue by Application (2019-2030)
7.3 US & Canada Milbemycin Oxime API Sales by Country
7.3.1 US & Canada Milbemycin Oxime API Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 US & Canada Milbemycin Oxime API Sales by Country (2019-2030)
7.3.3 US & Canada Milbemycin Oxime API Revenue by Country (2019-2030)
7.3.4 United States
7.3.5 Canada
8 Europe
8.1 Europe Milbemycin Oxime API Market Size by Type
8.1.1 Europe Milbemycin Oxime API Sales by Type (2019-2030)
8.1.2 Europe Milbemycin Oxime API Revenue by Type (2019-2030)
8.2 Europe Milbemycin Oxime API Market Size by Application
8.2.1 Europe Milbemycin Oxime API Sales by Application (2019-2030)
8.2.2 Europe Milbemycin Oxime API Revenue by Application (2019-2030)
8.3 Europe Milbemycin Oxime API Sales by Country
8.3.1 Europe Milbemycin Oxime API Revenue by Country: 2019 VS 2023 VS 2030
8.3.2 Europe Milbemycin Oxime API Sales by Country (2019-2030)
8.3.3 Europe Milbemycin Oxime API Revenue by Country (2019-2030)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Milbemycin Oxime API Market Size by Type
9.1.1 China Milbemycin Oxime API Sales by Type (2019-2030)
9.1.2 China Milbemycin Oxime API Revenue by Type (2019-2030)
9.2 China Milbemycin Oxime API Market Size by Application
9.2.1 China Milbemycin Oxime API Sales by Application (2019-2030)
9.2.2 China Milbemycin Oxime API Revenue by Application (2019-2030)
10 Asia (excluding China)
10.1 Asia Milbemycin Oxime API Market Size by Type
10.1.1 Asia Milbemycin Oxime API Sales by Type (2019-2030)
10.1.2 Asia Milbemycin Oxime API Revenue by Type (2019-2030)
10.2 Asia Milbemycin Oxime API Market Size by Application
10.2.1 Asia Milbemycin Oxime API Sales by Application (2019-2030)
10.2.2 Asia Milbemycin Oxime API Revenue by Application (2019-2030)
10.3 Asia Milbemycin Oxime API Sales by Region
10.3.1 Asia Milbemycin Oxime API Revenue by Region: 2019 VS 2023 VS 2030
10.3.2 Asia Milbemycin Oxime API Revenue by Region (2019-2030)
10.3.3 Asia Milbemycin Oxime API Sales by Region (2019-2030)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Milbemycin Oxime API Market Size by Type
11.1.1 Middle East, Africa and Latin America Milbemycin Oxime API Sales by Type (2019-2030)
11.1.2 Middle East, Africa and Latin America Milbemycin Oxime API Revenue by Type (2019-2030)
11.2 Middle East, Africa and Latin America Milbemycin Oxime API Market Size by Application
11.2.1 Middle East, Africa and Latin America Milbemycin Oxime API Sales by Application (2019-2030)
11.2.2 Middle East, Africa and Latin America Milbemycin Oxime API Revenue by Application (2019-2030)
11.3 Middle East, Africa and Latin America Milbemycin Oxime API Sales by Country
11.3.1 Middle East, Africa and Latin America Milbemycin Oxime API Revenue by Country: 2019 VS 2023 VS 2030
11.3.2 Middle East, Africa and Latin America Milbemycin Oxime API Revenue by Country (2019-2030)
11.3.3 Middle East, Africa and Latin America Milbemycin Oxime API Sales by Country (2019-2030)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 Livzon Pharmaceutical Group Inc
12.1.1 Livzon Pharmaceutical Group Inc Company Information
12.1.2 Livzon Pharmaceutical Group Inc Overview
12.1.3 Livzon Pharmaceutical Group Inc Milbemycin Oxime API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.1.4 Livzon Pharmaceutical Group Inc Milbemycin Oxime API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Livzon Pharmaceutical Group Inc Recent Developments
12.2 Zhejiang Hisun Pharmaceutical Co., Ltd
12.2.1 Zhejiang Hisun Pharmaceutical Co., Ltd Company Information
12.2.2 Zhejiang Hisun Pharmaceutical Co., Ltd Overview
12.2.3 Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.2.4 Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Zhejiang Hisun Pharmaceutical Co., Ltd Recent Developments
12.3 Hubei Honch Pharmaceutical Co.,Ltd
12.3.1 Hubei Honch Pharmaceutical Co.,Ltd Company Information
12.3.2 Hubei Honch Pharmaceutical Co.,Ltd Overview
12.3.3 Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.3.4 Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Hubei Honch Pharmaceutical Co.,Ltd Recent Developments
12.4 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD
12.4.1 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Company Information
12.4.2 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Overview
12.4.3 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.4.4 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Milbemycin Oxime API Industry Chain Analysis
13.2 Milbemycin Oxime API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Milbemycin Oxime API Production Mode & Process
13.4 Milbemycin Oxime API Sales and Marketing
13.4.1 Milbemycin Oxime API Sales Channels
13.4.2 Milbemycin Oxime API Distributors
13.5 Milbemycin Oxime API Customers
14 Milbemycin Oxime API Market Dynamics
14.1 Milbemycin Oxime API Industry Trends
14.2 Milbemycin Oxime API Market Drivers
14.3 Milbemycin Oxime API Market Challenges
14.4 Milbemycin Oxime API Market Restraints
15 Key Finding in The Global Milbemycin Oxime API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Livzon Pharmaceutical Group Inc
Zhejiang Hisun Pharmaceutical Co., Ltd
Hubei Honch Pharmaceutical Co.,Ltd
JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD
Ìý
Ìý
*If Applicable.
